148 related articles for article (PubMed ID: 17266193)
1. Monoamine oxidase isoform-dependent tautomeric influence in the recognition of 3,5-diaryl pyrazole inhibitors.
Chimenti F; Fioravanti R; Bolasco A; Manna F; Chimenti P; Secci D; Befani O; Turini P; Ortuso F; Alcaro S
J Med Chem; 2007 Feb; 50(3):425-8. PubMed ID: 17266193
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase.
Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Befani O; Turini P; Giovannini V; Mondovì B; Cirilli R; La Torre F
J Med Chem; 2004 Apr; 47(8):2071-4. PubMed ID: 15056004
[TBL] [Abstract][Full Text] [Related]
3. Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling.
Gallardo-Godoy A; Fierro A; McLean TH; Castillo M; Cassels BK; Reyes-Parada M; Nichols DE
J Med Chem; 2005 Apr; 48(7):2407-19. PubMed ID: 15801832
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of amine oxidases activity by 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives.
Manna F; Chimenti F; Bolasco A; Secci D; Bizzarri B; Befani O; Turini P; Mondovi B; Alcaro S; Tafi A
Bioorg Med Chem Lett; 2002 Dec; 12(24):3629-33. PubMed ID: 12443791
[TBL] [Abstract][Full Text] [Related]
5. Fluorinated phenylcyclopropylamines. 1. Synthesis and effect of fluorine substitution at the cyclopropane ring on inhibition of microbial tyramine oxidase.
Yoshida S; Meyer OG; Rosen TC; Haufe G; Ye S; Sloan MJ; Kirk KL
J Med Chem; 2004 Mar; 47(7):1796-806. PubMed ID: 15027872
[TBL] [Abstract][Full Text] [Related]
6. Simple, potent, and selective pyrrole inhibitors of monoamine oxidase types A and B.
Silvestri R; La Regina G; De Martino G; Artico M; Befani O; Palumbo M; Agostinelli E; Turini P
J Med Chem; 2003 Mar; 46(6):917-20. PubMed ID: 12620068
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibitors and computer modelling of the active site of monoamine oxidase.
Medvedev AE; Ivanov AS; Veselovsky AV
Neurobiology (Bp); 2000; 8(2):201-14. PubMed ID: 11061215
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of monoamine oxidases by coumarin-3-acyl derivatives: biological activity and computational study.
Chimenti F; Secci D; Bolasco A; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F
Bioorg Med Chem Lett; 2004 Jul; 14(14):3697-703. PubMed ID: 15203146
[TBL] [Abstract][Full Text] [Related]
9. Modeling of substrate-binding region of the active site of monoamine oxidase A.
Veselovsky AV; Medvedev AE; Tikhonova OV; Skvortsov VS; Ivanov AS
Biochemistry (Mosc); 2000 Aug; 65(8):910-6. PubMed ID: 11002183
[TBL] [Abstract][Full Text] [Related]
10. Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders.
Binda C; Newton-Vinson P; Hubálek F; Edmondson DE; Mattevi A
Nat Struct Biol; 2002 Jan; 9(1):22-6. PubMed ID: 11753429
[TBL] [Abstract][Full Text] [Related]
11. [Use of selective inhibitors for computer modeling of the monoamine oxidase active site].
Veselovskiĭ AV; Ivanov AS; Medvedev AE
Vopr Med Khim; 1997; 43(6):527-36. PubMed ID: 9503570
[TBL] [Abstract][Full Text] [Related]
12. Fluorinated phenylcyclopropylamines. Part 4: effects of aryl substituents and stereochemistry on the inhibition of monoamine oxidases by 1-aryl-2-fluoro-cyclopropylamines.
Ye S; Yoshida S; Fröhlich R; Haufe G; Kirk KL
Bioorg Med Chem; 2005 Apr; 13(7):2489-99. PubMed ID: 15755651
[TBL] [Abstract][Full Text] [Related]
13. Molecular determinants of MAO selectivity in a series of indolylmethylamine derivatives: biological activities, 3D-QSAR/CoMFA analysis, and computational simulation of ligand recognition.
Morón JA; Campillo M; Perez V; Unzeta M; Pardo L
J Med Chem; 2000 May; 43(9):1684-91. PubMed ID: 10794685
[TBL] [Abstract][Full Text] [Related]
14. Fluorinated phenylcyclopropylamines. Part 3: Inhibition of monoamine oxidase A and B.
Yoshida S; Rosen TC; Meyer OG; Sloan MJ; Ye S; Haufe G; Kirk KL
Bioorg Med Chem; 2004 May; 12(10):2645-52. PubMed ID: 15110846
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel N-substituted imidazolecarboxylic acid hydrazides as monoamine oxidase inhibitors.
Hadizadeh F; Ghodsi R
Farmaco; 2005 Mar; 60(3):237-40. PubMed ID: 15784243
[TBL] [Abstract][Full Text] [Related]
16. 1-N-Substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: a novel cholinesterase and selective monoamine oxidase B inhibitors for the treatment of Parkinson's and Alzheimer's diseases.
Ucar G; Gokhan N; Yesilada A; Bilgin AA
Neurosci Lett; 2005 Jul; 382(3):327-31. PubMed ID: 15925113
[TBL] [Abstract][Full Text] [Related]
17. Enantiomers of C(5)-chiral 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives: Analytical and semipreparative HPLC separation, chiroptical properties, absolute configuration, and inhibitory activity against monoamine oxidase.
Cirilli R; Ferretti R; Gallinella B; Turchetto L; Bolasco A; Secci D; Chimenti P; Pierini M; Fares V; Befani O; La Torre F
Chirality; 2004 Nov; 16(9):625-36. PubMed ID: 15382204
[TBL] [Abstract][Full Text] [Related]
18. [Modeling of monoamine oxidase B active site by computer moulding].
Veselovskiĭ AV; Tikhonova OV; Ivanov AS; Medvedev AE
Vopr Med Khim; 2001; 47(6):642-51. PubMed ID: 11925756
[TBL] [Abstract][Full Text] [Related]
19. 1-N-substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: synthesis and evaluation as MAO inhibitors.
Gökhan N; Yeşilada A; Uçar G; Erol K; Bilgin AA
Arch Pharm (Weinheim); 2003 Aug; 336(8):362-71. PubMed ID: 14502756
[TBL] [Abstract][Full Text] [Related]
20. Molecular interaction between reversible MAO-A inhibitors and the enzyme. Application to aryloxazolidinone, a prototype series.
Ooms F; Jegham S; George P; Durant F; Wouters J
Neurobiology (Bp); 2000; 8(1):81-98. PubMed ID: 11008880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
